Key Metrics
9.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.84
5-Year SI
5-year SI
- N/A 2-year SI
- 0.86 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Neurology
SJR
- Q1 Neurology
- Q1 Pharmacology
- Q1 Neurology (clinical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.87
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Cladribine
- Multiple sclerosis
- Parkinson's disease
- Ischemic stroke
- Alemtuzumab
- Patient satisfaction
- Breast milk
- Cerebrospinal fluid
- Placebo
- Progressive multifocal leukoencephalopathy
- Magnetic resonance imaging
- Acute ischemic stroke
- Confidence interval
- Safety profile
- Quality of life
- Peginterferon beta-1a
- Myopathy
- Dimethyl fumarate
- Natalizumab
- Rituximab
Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 15 |
| Article Processing Charges | USD 2300 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Therapeutic Advances in Neurological Disorders ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Anti-NMDA-receptor encephalitis and concurrent neuroborreliosis misdiagnosed for post-COVID-19-syndrome: a case report.
- 1 Jan 24
- Therapeutic advances in neurological disorders
-
Full paper
Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons.
- 1 Jan 24
- Therapeutic advances in neurological disorders
-
Full paper
Machine Learning-Based Prediction of Stroke in Emergency Departments.
- 1 Jan 24
- Therapeutic advances in neurological disorders
-
Full paper
Patisiran exposure in early pregnancy: a case report.
- 1 Jan 24
- Therapeutic advances in neurological disorders
-
Full paper
Real-world evidence and patient preference for subcutaneous versus intravenous natalizumab in the treatment of relapsing-remitting multiple sclerosis - initial results from the observational SISTER study.
- 1 Jan 24
- Therapeutic advances in neurological disorders
-
Full paper
Genetic and phenotypic analyses of PRRT2 positive and negative paroxysmal kinesigenic dyskinesia.
- 1 Jan 24
- Therapeutic advances in neurological disorders
Scite analysis
Powered by scite_
871 articles received 21.1k citations see all
- 634 Supporting
- 19,588 Mentioning
- 103 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 11 Corrections
- 9 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
12%
4 to 6 months
52%
7 to 9 months
29%
Above 9 months
8%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Therapeutic Advances in Neurological Disorders been actively publishing?
Therapeutic Advances in Neurological Disorders has been in operation since 2008 till date.
What is the publishing frequency of Therapeutic Advances in Neurological Disorders ?
Therapeutic Advances in Neurological Disorders published with a Continuous publication frequency.
How many articles did Therapeutic Advances in Neurological Disorders publish last years ?
In 2023, Therapeutic Advances in Neurological Disorders published 58 articles.
What is the eISSN & pISSN for Therapeutic Advances in Neurological Disorders ?
For Therapeutic Advances in Neurological Disorders,eISSN is 1756-2864 and pISSN is1756-2856.
What is Citescore for Therapeutic Advances in Neurological Disorders ?
Citescore for Therapeutic Advances in Neurological Disorders is 9.4.
What is SNIP score for Therapeutic Advances in Neurological Disorders ?
SNIP score for Therapeutic Advances in Neurological Disorders is 1.87.
What is the SJR for Therapeutic Advances in Neurological Disorders ?
SJR for Therapeutic Advances in Neurological Disorders is Q1.
Who is the publisher of Therapeutic Advances in Neurological Disorders ?
SAGE PUBLICATIONS LTD is the publisher of Therapeutic Advances in Neurological Disorders.